Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.80%), Hang Seng Futures (0.62%), ASX SPI 200 (0.39%), S&P Futures +0.06%

Oct 07 ,2026

  • Synopsis:

    • Asian markets set for negative start to Thursday trade. Futures signaling opening declines in Japan, Hong Kong and a flat start in South Korea. Initial weakness in Australia. Mainland China resumes trade following National Day holiday. S&P 500 futures unchanged afterhours. Australian bonds strengthening with curve steepening. FX markets steady after euro fell sharply against dollar. Crude lifting from earlier lows. Gold little changed while silver extending declines. Bitcoin down to two-week low.

    • Samsung Electronics (005930.KS) Q3 preliminary revenue and operating profit came in below estimates. Previews were looking beyond quarterly change in earnings ahead of company's full Q3 presentation later this month. LTA updates, including pace of contract price growth, extent of FX headwinds, competitive pressures, updates on memory shortfall timeline, and margin impact from higher memory costs among focus areas.

    • Rate stabilization attributed strong 10Y Treasury auction, helping to dampen earlier upward pressure on yields from renewed concerns about France's fiscal position and crowing out effects of AI-driven debt issuance (SpaceX's $40B raise to buy Nvidia chips). Rate pullback also corresponded with pullback in oil as markets looked past pickup in kinetic action in SoH and Yemen, and report Trump is seeking to develop strike plans against Iran.

  • Pre-open Company News:

    • 8630.JP -- Sompo Holdings unit Sompo Japan reports data from 60K customer inquiries may have been leaked due to unauthorized access to Scala Communications servers

    • 3017.TT -- Taiwan's Ministry of Justice Investigation Bureau searches and investigates specific employees at Asia Vital Components in relation to unit Fositek

    • GLNG -- Golar LNG acquires conversion vessel for 4th FLNG

    • 4578.JP -- Otsuka unit completes rolling submission of supplemental BLA to FDA for VOYXACT

    • 6594.JP -- Nidec holder Oasis Management urges company to begin preliminary review of options to take company private

    • 128940.KS -- Hanmi Pharmaceutical receives NFDS approval for GLP-1 receptor agonist efpeglenatide for obesity indication

    • 300558.CH -- Betta Pharmaceuticals receives U.S. FDA clinical trial approval for BPI-572270 capsule for advanced solid tumor

    • 9044.JP -- Nankai initiated buy at BofA

    • 500265.IN -- Maharashtra Seamless re-approves demerger of pipe businesses following review

    • 3347.HK -- Hangzhou Tigermed Consulting downgraded to equal-weight from overweight at Morgan Stanley

    • QTRX -- Quanterix and Innovita expand IVD access in China with NMPA approvals for Quanterix HD-X & SR-X instruments alongside four neurological disease biomarker testing kits

    • 6141.JP -- DMG MORI resumed buy at Citi; prior rating was buy

    • 005930.KS -- Samsung Electronics reports preliminary Q3 revenue KRW195.00T vs StreetAccount KRW204.050T

    • 990.HK -- Deep Source provides update on Malaysia data centre project; signs colocation services agreement for 67MW of capacity

  • On Deck:

    • Japan:

      • Earnings:

        • Seven & I Holdings (3382.JP), FAST RETAILING (9983.JP), Kewpie (2809.JP), Rorze Corp (6323.JP), Sugi Holdings (7649.JP), Onward Holdings (8016.JP), Life Corp. (8194.JP), Fuji Co. (8278.JP), Nomura Co. (9716.JP), Yoshinoya Holdings (9861.JP)

    • Australia:

      • Economic:

        • 11:00 AEST: Consumer Inflation Expectation; consensus

    • Taiwan:

      • Economic:

        • 16:00 TST: Export NSA Y/Y; consensus +42%

  • Market Data:

    • Gold (Dec 26): ($7.40) or (0.18%) to $4133.30

    • WTI Crude (Nov 26): +$0.51 or +0.58% to $88.79

    • $-¥: (0.13) or (0.08%) to 157.9740

    • $-KRW: +0.74 or +0.06% to 1339.2200

    • A$-$: (0.00) or (0.30%) to 0.6962

    • $-INR: +0.36 or +0.37% to 96.7568

    • $-CNY: (0.00) or (0.01%) to 6.7038

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE